Aligos therapeutics to announce 4th quarter 2024 financial results on march 10, 2025

South san francisco, calif., march 03, 2025 (globe newswire) -- aligos therapeutics, inc. (nasdaq: algs), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced that it will report the company's fourth quarter 2024 financial results on monday, march 10, 2025, before the open of the u.s. financial markets.
ALGS Ratings Summary
ALGS Quant Ranking